Literature DB >> 15133616

[Emergencies in allergology].

C Bauer1, F Ruëff, B Przybilla.   

Abstract

The clinical presentation of allergological emergencies is heterogeneous. The most important conditions are anaphylaxis (which is frequent) and Stevens-Johnson syndrome or toxic epidermal necrolysis (which are rare). In the acute phase it is most important to recognize the exogenous elicitation of the condition as soon as possible, otherwise severe sequelae, even death of the patient, may occur. Management is based on immediate elimination of possible causative agents and symptomatic therapeutic measures. Furthermore, allergological diagnostics are necessary without delay to identify what has elicited the reaction. This information makes possible long-term treatment in order to avoid further hypersensitivity reactions.

Entities:  

Mesh:

Year:  2004        PMID: 15133616     DOI: 10.1007/s00105-004-0735-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   1.198


  13 in total

Review 1.  [Toxic epidermal necrolysis (drug-induced Lyell's syndrome). I. Clinical features and differential diagnosis].

Authors:  A Konstantinow; W Mühlbauer; B R Balda; J Ring
Journal:  Dtsch Med Wochenschr       Date:  2001-02-09       Impact factor: 0.628

2.  Managing anaphylaxis: effective emergency and long-term care are necessary.

Authors:  S Walker; A Sheikh
Journal:  Clin Exp Allergy       Date:  2003-08       Impact factor: 5.018

3.  Fatal posture in anaphylactic shock.

Authors:  Richard S H Pumphrey
Journal:  J Allergy Clin Immunol       Date:  2003-08       Impact factor: 10.793

4.  Population study of food allergy in France.

Authors:  G Kanny; D A Moneret-Vautrin; J Flabbee; E Beaudouin; M Morisset; F Thevenin
Journal:  J Allergy Clin Immunol       Date:  2001-07       Impact factor: 10.793

5.  [Diagnosis and therapy of urticaria].

Authors:  T Zuberbier; W Aberer; J Grabbe; K Hartmann; H Merk; M Ollert; F Ruëff; B Wedi; J Wenning
Journal:  J Dtsch Dermatol Ges       Date:  2003-08       Impact factor: 5.584

Review 6.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997.

Authors: 
Journal:  Allergy       Date:  1998       Impact factor: 13.146

7.  Low N-acetylating capacity in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  A Dietrich; Y Kawakubo; B Rzany; M Mockenhaupt; J C Simon; E Schöpf
Journal:  Exp Dermatol       Date:  1995-10       Impact factor: 3.960

8.  A population study of food intolerance.

Authors:  E Young; M D Stoneham; A Petruckevitch; J Barton; R Rona
Journal:  Lancet       Date:  1994-05-07       Impact factor: 79.321

9.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?

Authors:  I Garcia-Doval; L LeCleach; H Bocquet; X L Otero; J C Roujeau
Journal:  Arch Dermatol       Date:  2000-03

10.  Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis.

Authors:  P Wolkenstein; J Latarjet; J C Roujeau; C Duguet; S Boudeau; L Vaillant; M Maignan; M H Schuhmacher; B Milpied; A Pilorget; H Bocquet; C Brun-Buisson; J Revuz
Journal:  Lancet       Date:  1998-11-14       Impact factor: 79.321

View more
  2 in total

1.  [Toxic epidermal necrolysis].

Authors:  V Lewerenz; D Bruch-Gerharz; T Ruzicka; R Kruse
Journal:  Hautarzt       Date:  2006-04       Impact factor: 0.751

2.  13-year overview of serious adverse drug reactions following subcutaneous specific immunotherapy with a chemically modified allergen preparation.

Authors:  Andreas Distler; Debbie Pappelendam
Journal:  Allergo J Int       Date:  2015-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.